Skip to main content
OpenTrials
Completed

NCT Number: NCT05971836

The Molecular Basis of Inherited Reproductive Disorders

The goal of this study is to learn more about the genes that control puberty and reproduction in humans.

Completed

Looking for future studies?

Notify Me

Key information

About this study

All study subjects will undergo the same activities. Subjects will provide up to five tubes of blood for genetic analysis, complete a smell test, and answer questions about their health and family history.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Participants must be healthy controls or belong to one of the following categories:

  • Failure to go through a normal, age-appropriate, spontaneous puberty and low sex steroid levels in the setting of low/normal gonadotropins or,
  • Abnormally early development of puberty or,
  • Normal puberty with subsequent development of low gonadotropin levels or,
  • Evidence of a reproductive disorder with high gonadotropin levels or,
  • Pre-pubertal individuals with features suggestive of hypogonadotropic hypogonadism or,
  • Affected and unaffected family members of individuals that fit criteria above

Treatment and study plan

Primary outcomes

  1. Genetic variation

    Time frame: Day 1

    Identification of one or more genetic variations related to reproductive disorders

Sponsors and collaborators

Lead sponsor

Stephanie B. Seminara, MD

Other

Registry information

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Aug 2, 2023
Registry last updated
Jul 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.